Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 769 M772 M780 M759 M827 M927 M 3.29 B Research & development 193 M189 M183 M174 M189 M178 M 724 M Operating income 152 M214 M1.69 B125 M81 M181 M 2.08 B Non-Operating Income, Total -11 M-8 M-5 M-15 M-4 M-9 M -33 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000000 0 Unusual income/expense -11 M-8 M-5 M-15 M-4 M-9 M -33 M Pretax income 38 M103 M1.51 B58 M16 M108 M 1.7 B Equity in earnings —————— — Taxes -99 M13 M248 M-5 M3 M15 M 261 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 137 M90 M1.27 B63 M13 M92 M 1.43 B Discontinued operations —————— — Net income 137 M90 M1.27 B63 M13 M92 M 1.43 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 137 M90 M1.27 B63 M13 M92 M 1.43 B Basic earnings per share (Basic EPS) 0.790.527.260.370.070.53 8.23 Diluted earnings per share (Diluted EPS) 0.780.517.220.370.070.53 8.19 Average basic shares outstanding 173.7 M174.1 M174.3 M174.1 M174.2 M172.7 M — Diluted shares outstanding 174.8 M175.2 M175.4 M175.3 M175.5 M173.3 M — EBITDA 1.14 B1.24 B3.53 B1.79 B1.04 B1.15 B 7.5 B EBIT 1.01 B1.11 B3.41 B1.67 B901 M1.01 B 7 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 129 M122 M121 M117 M135 M133 M 506 M